{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T02:07:20Z","timestamp":1763518040034,"version":"3.45.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11244-1","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T13:15:00Z","timestamp":1763471700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Philadelphia chromosome-positive acute lymphoblastic leukemia: exploring microRNA-based strategies to improve outcomes"],"prefix":"10.1007","volume":"53","author":[{"given":"Setare","family":"Kheyrandish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloofar","family":"Pilehvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Rastgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi Allah","family":"bakhshian-Farsani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahram","family":"Chahardouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrbano","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Gharehbaghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"1","key":"11244_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","volume":"482","author":"AS Duffield","year":"2023","unstructured":"Duffield AS, Mullighan CG, Borowitz MJ (2023) International consensus classification of acute lymphoblastic leukemia\/lymphoma. Virchows Arch 482(1):11\u201326","journal-title":"Virchows Arch"},{"issue":"1","key":"11244_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL et al (2025) Cancer statistics, 2025. CA Cancer J Clin 75(1):10\u201345","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"11244_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/ijlh.14042","volume":"45","author":"T Kirtek","year":"2023","unstructured":"Kirtek T et al (2023) Spontaneous remission of acute lymphoblastic leukemia: a series of nine cases and a review of literature. Int J Lab Hematol 45(4):489\u2013495","journal-title":"Int J Lab Hematol"},{"key":"11244_CR4","unstructured":"Board PPTE (2025) Childhood acute lymphoblastic leukemia treatment (PDQ\u00ae), in PDQ Cancer Information Summaries. National Cancer Institute (US)"},{"issue":"1","key":"11244_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1182\/hematology.2022000338","volume":"2022","author":"MJ Wieduwilt","year":"2022","unstructured":"Wieduwilt MJ (2022) Ph\u2009+\u2009ALL in 2022: is there an optimal approach? Hematology 2022(1):206\u2013212","journal-title":"Hematology"},{"key":"11244_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11899-011-0093-y","volume":"6","author":"MS Mathisen","year":"2011","unstructured":"Mathisen MS et al (2011) Role of tyrosine kinase inhibitors in the management of Philadelphia chromosome\u2013positive acute lymphoblastic leukemia. Curr Hematol Malig Rep 6:187\u2013194","journal-title":"Curr Hematol Malig Rep"},{"issue":"7","key":"11244_CR7","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1038\/s41375-020-01082-4","volume":"35","author":"S Adnan-Awad","year":"2021","unstructured":"Adnan-Awad S et al (2021) Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets. Leukemia 35(7):1964\u20131975","journal-title":"Leukemia"},{"issue":"5","key":"11244_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11912-012-0247-7","volume":"14","author":"T Liu-Dumlao","year":"2012","unstructured":"Liu-Dumlao T et al (2012) Philadelphia-positive acute lymphoblastic leukemia: current treatment options. Curr Oncol Rep 14(5):387\u2013394","journal-title":"Curr Oncol Rep"},{"issue":"S1","key":"11244_CR9","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.5045\/br.2020.S006","volume":"55","author":"H-S Park","year":"2020","unstructured":"Park H-S (2020) Current treatment strategies for Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Blood Res 55(S1):S32\u2013S36","journal-title":"Blood Res"},{"key":"11244_CR10","volume":"18","author":"R Takiar","year":"2022","unstructured":"Takiar R et al (2022) Real world outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation-a single institution experience. Leuk Res Rep 18:100352","journal-title":"Leuk Res Rep"},{"key":"11244_CR11","doi-asserted-by":"crossref","unstructured":"11. Prockop S and Wachter F (2023) The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia. Best Prac & Res Clinical Haematology, 36(3):101485","DOI":"10.1016\/j.beha.2023.101485"},{"issue":"12","key":"11244_CR12","doi-asserted-by":"publisher","DOI":"10.62347\/ZWAM1063","volume":"14","author":"L Ma","year":"2024","unstructured":"Ma L (2024) Retrospective analysis of clinical and molecular characteristics as prognostic factors in adult T-cell lymphoblastic lymphoma. Am J Cancer Res 14(12):5851","journal-title":"Am J Cancer Res"},{"issue":"2","key":"11244_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/10428194.2024.2416569","volume":"66","author":"J-M Ribera","year":"2025","unstructured":"Ribera J-M, Torrent A (2025) Novel prognostic factors and therapeutic advances in adult acute lymphoblastic leukemia. Leuk Lymphoma 66(2):218\u2013228","journal-title":"Leuk Lymphoma"},{"key":"11244_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.genrep.2016.07.008","volume":"4","author":"N Sanddhya","year":"2016","unstructured":"Sanddhya N et al (2016) Role of miR-125b and miR-203 expressions in the pathogenesis of BCR-ABL\u2009+\u2009acute lymphoblastic leukemia (ALL). Gene Rep 4:253\u2013257","journal-title":"Gene Rep"},{"issue":"8","key":"11244_CR15","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1002\/jcp.26290","volume":"233","author":"S Ultimo","year":"2018","unstructured":"Ultimo S et al (2018) Roles and clinical implications of MicroRNAs in acute lymphoblastic leukemia. J Cell Physiol 233(8):5642\u20135654","journal-title":"J Cell Physiol"},{"key":"11244_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-021-00395-z","volume":"27","author":"Y-h Lu","year":"2021","unstructured":"Lu Y-h, Huang Z-y (2021) Global identification of circular RNAs in Imatinib (IM) resistance of chronic myeloid leukemia (CML) by modulating signaling pathways of circ_0080145\/miR-203\/ABL1 and circ 0051886\/miR-637\/ABL1. Mol Med 27:1\u201313","journal-title":"Mol Med"},{"issue":"12","key":"11244_CR17","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/cdd.2013.125","volume":"20","author":"E Mogilyansky","year":"2013","unstructured":"Mogilyansky E, Rigoutsos I (2013) The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ 20(12):1603\u20131614","journal-title":"Cell Death Differ"},{"issue":"3","key":"11244_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/PPO.0b013e318258b60a","volume":"18","author":"CP Concepcion","year":"2012","unstructured":"Concepcion CP, Bonetti C, Ventura A (2012) The microRNA-17-92 family of microRNA clusters in development and disease. Cancer J 18(3):262\u2013267","journal-title":"Cancer J"},{"issue":"1","key":"11244_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/bdr2.2273","volume":"116","author":"Y Cao","year":"2024","unstructured":"Cao Y et al (2024) The miR-17\u201092 cluster in cardiac health and disease. Birth Defects Res 116(1):e2273","journal-title":"Birth Defects Res"},{"issue":"3","key":"11244_CR20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/leu.2013.361","volume":"28","author":"M Scherr","year":"2014","unstructured":"Scherr M et al (2014) Differential expression of miR-17\u223c 92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia. Leukemia 28(3):554\u2013565","journal-title":"Leukemia"},{"issue":"2","key":"11244_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/22115374MTAwnOTIxw","volume":"9","author":"F Zacharias","year":"2020","unstructured":"Zacharias F (2020) Micrornas determining carcinogenesis by regulating oncogenes and tumor suppressor genes during cell cycle. MicroRNA 9(2):82\u201392","journal-title":"MicroRNA"},{"issue":"5","key":"11244_CR22","first-page":"1019","volume":"37","author":"S Qi","year":"2024","unstructured":"Qi S, Huang J, Long R (2024) The synergistic effect of miR-203 and cytarabine on the Inhibition of cell proliferation and induction of apoptosis in chronic myelogenous leukemia cells. Pak J Pharm Sci 37(5):1019\u20131025","journal-title":"Pak J Pharm Sci"},{"key":"11244_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1288501","volume":"14","author":"JNG William","year":"2024","unstructured":"William JNG et al (2024) SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies. Front Oncol 14:1288501","journal-title":"Front Oncol"},{"issue":"7298","key":"11244_CR24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nature09092","volume":"465","author":"S Cheloufi","year":"2010","unstructured":"Cheloufi S et al (2010) A dicer-independent miRNA biogenesis pathway that requires ago catalysis. Nature 465(7298):584\u2013589","journal-title":"Nature"},{"key":"11244_CR25","doi-asserted-by":"crossref","unstructured":"Yu D et al (2010) miR-451 protects against erythroid oxidant stress by repressing 14-3-3\u03b6, Genes & development 24(15):1620\u20131633","DOI":"10.1101\/gad.1942110"},{"key":"11244_CR26","doi-asserted-by":"crossref","unstructured":"Zhu J et al (2024) miR-144\/451: A regulatory role in inflammation. Current Molecular Medicine","DOI":"10.2174\/0115665240327822241104060015"},{"issue":"4","key":"11244_CR27","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.gendis.2021.10.009","volume":"9","author":"M Sajjadi-Dokht","year":"2022","unstructured":"Sajjadi-Dokht M et al (2022) MicroRNAs and JAK\/STAT3 signaling: a new promising therapeutic axis in blood cancers. Genes Dis 9(4):849\u2013867","journal-title":"Genes Dis"},{"issue":"10","key":"11244_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105317","volume":"22","author":"K G\u0119barowska","year":"2021","unstructured":"G\u0119barowska K et al (2021) Microrna as a prognostic and diagnostic marker in T-cell acute lymphoblastic leukemia. Int J Mol Sci 22(10):5317","journal-title":"Int J Mol Sci"},{"key":"11244_CR29","doi-asserted-by":"publisher","DOI":"10.4103\/jcar.JCar_27_20","volume":"20","author":"F Lalfamkima","year":"2021","unstructured":"Lalfamkima F et al (2021) Clinical diagnostic criteria versus advanced imaging in prediction of cervical lymph node metastasis in oral squamous cell carcinomas: a magnetic resonance imaging based study. J Carcinog 20:3","journal-title":"J Carcinog"},{"issue":"3","key":"11244_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032834","volume":"7","author":"J Fei","year":"2012","unstructured":"Fei J et al (2012) MiR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML). PLoS One 7(3):e32834","journal-title":"PLoS One"},{"issue":"8","key":"11244_CR31","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/bjc.2013.562","volume":"109","author":"X Li","year":"2013","unstructured":"Li X et al (2013) Microrna-100\/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R\/mTOR signalling pathways. Br J Cancer 109(8):2189\u20132198","journal-title":"Br J Cancer"},{"issue":"12","key":"11244_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122614","volume":"18","author":"GR Fries","year":"2017","unstructured":"Fries GR, Gassen NC, Rein T (2017) The FKBP51 glucocorticoid receptor co-chaperone: regulation, function, and implications in health and disease. Int J Mol Sci 18(12):2614","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11244_CR33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","volume":"15","author":"JE Fish","year":"2008","unstructured":"Fish JE et al (2008) MiR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15(2):272\u2013284","journal-title":"Dev Cell"},{"issue":"2","key":"11244_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","volume":"15","author":"S Wang","year":"2008","unstructured":"Wang S et al (2008) The endothelial-specific MicroRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15(2):261\u2013271","journal-title":"Dev Cell"},{"issue":"3","key":"11244_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu S et al (2021) Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev 73(3):924\u2013967","journal-title":"Pharmacol Rev"},{"issue":"1","key":"11244_CR36","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1100\/tsw.2010.198","volume":"10","author":"J Meister","year":"2010","unstructured":"Meister J, Schmidt MH (2010) MiR-126 and miR\u2010126*: new players in cancer. Sci World J 10(1):2090\u20132100","journal-title":"Sci World J"},{"issue":"4","key":"11244_CR37","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR (2018) Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res 122(4):624\u2013638","journal-title":"Circ Res"},{"issue":"6","key":"11244_CR38","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.stem.2012.09.001","volume":"11","author":"ER Lechman","year":"2012","unstructured":"Lechman ER et al (2012) Attenuation of miR-126 activity expands HSC in vivo without exhaustion. Cell Stem Cell 11(6):799\u2013811","journal-title":"Cell Stem Cell"},{"issue":"6","key":"11244_CR39","first-page":"7241","volume":"14","author":"Y Cheng","year":"2017","unstructured":"Cheng Y et al (2017) 38 predicts depression and poor outcome in esophageal cancer. Oncol Lett 14(6):7241\u20137249","journal-title":"Oncol Lett"},{"issue":"7","key":"11244_CR40","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41375-023-01933-w","volume":"37","author":"J Qiao","year":"2023","unstructured":"Qiao J et al (2023) Targeting miR-126 in ph\u2009+\u2009acute lymphoblastic leukemia. Leukemia 37(7):1540\u20131544","journal-title":"Leukemia"},{"issue":"2","key":"11244_CR41","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3892\/or.2016.4869","volume":"36","author":"L Shen","year":"2016","unstructured":"Shen L et al (2016) COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance. Oncol Rep 36(2):877\u2013885","journal-title":"Oncol Rep"},{"issue":"10","key":"11244_CR42","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1038\/s41375-023-02009-5","volume":"37","author":"C Caserta","year":"2023","unstructured":"Caserta C et al (2023) miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease. Leukemia 37(10):1994\u20132005","journal-title":"Leukemia"},{"issue":"12","key":"11244_CR43","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s41556-022-01025-4","volume":"24","author":"S Efstathiou","year":"2022","unstructured":"Efstathiou S et al (2022) ER-associated RNA silencing promotes ER quality control. Nat Cell Biol 24(12):1714\u20131725","journal-title":"Nat Cell Biol"},{"issue":"4","key":"11244_CR44","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3892\/ol.2014.2328","volume":"8","author":"S-L Lei","year":"2014","unstructured":"Lei S-L et al (2014) Regulatory roles of microRNA\u2013708 and microRNA\u201331 in proliferation, apoptosis and invasion of colorectal cancer cells. Oncol Lett 8(4):1768\u20131774","journal-title":"Oncol Lett"},{"issue":"6","key":"11244_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.252","volume":"8","author":"Z Chen","year":"2017","unstructured":"Chen Z et al (2017) The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2. Cell Death Dis 8(6):e2859\u2013e2859","journal-title":"Cell Death Dis"},{"issue":"51","key":"11244_CR46","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.18632\/oncotarget.27840","volume":"11","author":"NJ Monteleone","year":"2020","unstructured":"Monteleone NJ, Lutz CS (2020) Mir-708-5p enhances erlotinib\/paclitaxel efficacy and overcomes chemoresistance in lung cancer cells. Oncotarget 11(51):4699","journal-title":"Oncotarget"},{"issue":"13","key":"11244_CR47","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1158\/1078-0432.CCR-11-2857","volume":"18","author":"JS Jang","year":"2012","unstructured":"Jang JS et al (2012) Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res 18(13):3658\u20133667","journal-title":"Clin Cancer Res"},{"key":"11244_CR48","doi-asserted-by":"crossref","unstructured":"Li G et al (2015) MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration. Biomed & Pharma 73:154\u2013159","DOI":"10.1016\/j.biopha.2015.05.010"},{"issue":"9","key":"11244_CR49","first-page":"5338","volume":"11","author":"S Sun","year":"2019","unstructured":"Sun S et al (2019) miRNA-708 functions as a tumor suppressor in colorectal cancer by targeting ZEB1 through Akt\/mTOR signaling pathway. Am J Translational Res 11(9):5338","journal-title":"Am J Translational Res"},{"issue":"2","key":"11244_CR50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/leu.2008.286","volume":"23","author":"D Schotte","year":"2009","unstructured":"Schotte D et al (2009) Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia 23(2):313\u2013322","journal-title":"Leukemia"},{"issue":"9","key":"11244_CR51","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/leu.2011.105","volume":"25","author":"D Schotte","year":"2011","unstructured":"Schotte D et al (2011) Discovery of new MicroRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia. Leukemia 25(9):1389\u20131399","journal-title":"Leukemia"},{"issue":"24","key":"11244_CR52","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1093\/hmg\/ddr428","volume":"20","author":"B-W Han","year":"2011","unstructured":"Han B-W et al (2011) A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL. Hum Mol Genet 20(24):4903\u20134915","journal-title":"Hum Mol Genet"},{"key":"11244_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114261","author":"K Liao","year":"2024","unstructured":"Liao K et al (2024) Critical roles of the miR-17\u223c 92 family in thymocyte development, leukemogenesis, and autoimmunity. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2024.114261","journal-title":"Cell Rep"},{"issue":"9","key":"11244_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ph13090241","volume":"13","author":"S Haque","year":"2020","unstructured":"Haque S, Vaiselbuh SR (2020) Silencing of exosomal miR-181a reverses pediatric acute lymphocytic leukemia cell proliferation. Pharmaceuticals 13(9):241","journal-title":"Pharmaceuticals"},{"issue":"3","key":"11244_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1635","volume":"12","author":"J Eniafe","year":"2021","unstructured":"Eniafe J, Jiang S (2021) Microrna-99 family in cancer and immunity. WIREs RNA 12(3):e1635","journal-title":"WIREs RNA"},{"issue":"4","key":"11244_CR56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3892\/ijmm.2025.5508","volume":"55","author":"L Zhang","year":"2025","unstructured":"Zhang L et al (2025) miR-100: A key tumor suppressor regulatory factor in human malignant tumors. Int J Mol Med 55(4):67","journal-title":"Int J Mol Med"},{"issue":"5","key":"11244_CR57","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/leu.2013.357","volume":"28","author":"S Emmrich","year":"2014","unstructured":"Emmrich S et al (2014) MiR-9 is a tumor suppressor in pediatric AML with t (8; 21). Leukemia 28(5):1022\u20131032","journal-title":"Leukemia"},{"issue":"5842","key":"11244_CR58","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"317","author":"J Kim","year":"2007","unstructured":"Kim J et al (2007) A microRNA feedback circuit in midbrain dopamine neurons. Science 317(5842):1220\u20131224","journal-title":"Science"},{"issue":"22","key":"11244_CR59","first-page":"4473","volume":"121","author":"AA Khan","year":"2013","unstructured":"Khan AA et al (2013) MicroRNA-17\u223c 92 regulates effector and memory CD8 T-cell fates by modulating proliferation in response to infections. Blood. J Am Soc Hematol 121(22):4473\u20134483","journal-title":"J Am Soc Hematol"},{"key":"11244_CR60","doi-asserted-by":"crossref","unstructured":"Akbari, B., et al., Epigenetic strategies to boost CAR T\u00a0cell therapy. Molecular Therapy, 2021. 29(9): pp. 2640\u20132659","DOI":"10.1016\/j.ymthe.2021.08.003"},{"key":"11244_CR61","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.lungcan.2017.02.020","volume":"108","author":"J Zhao","year":"2017","unstructured":"Zhao J et al (2017) Synergy between next generation EGFR tyrosine kinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer. Lung Cancer 108:96\u2013102","journal-title":"Lung Cancer"},{"key":"11244_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1067974","volume":"12","author":"HS Budi","year":"2023","unstructured":"Budi HS et al (2023) The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy. Front Oncol 12:1067974","journal-title":"Front Oncol"},{"issue":"3","key":"11244_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031469","volume":"25","author":"AA Seyhan","year":"2024","unstructured":"Seyhan AA (2024) Trials and tribulations of MicroRNA therapeutics. Int J Mol Sci 25(3):1469","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11244_CR64","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/ejh.ejh_86_24","volume":"50","author":"HA Nafady","year":"2025","unstructured":"Nafady HA et al (2025) Value of microRNA-30a in Philadelphia positive leukemic patients. Egypt J Haematol 50(1):107\u2013112","journal-title":"Egypt J Haematol"},{"key":"11244_CR65","doi-asserted-by":"publisher","DOI":"10.4103\/amsr.amsr_46_24","author":"A Hazra","year":"2024","unstructured":"Hazra A (2024) MicroRNA therapeutics: dawning of a new era in precision medicine. Ann Med Sci Res. https:\/\/doi.org\/10.4103\/amsr.amsr_46_24","journal-title":"Ann Med Sci Res"},{"issue":"6","key":"11244_CR66","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener C, Keller A, Meese E (2022) Emerging concepts of MiRNA therapeutics: from cells to clinic. Trends Genet 38(6):613\u2013626","journal-title":"Trends Genet"},{"issue":"1","key":"11244_CR67","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12967-020-02415-8","volume":"18","author":"B Egyed","year":"2020","unstructured":"Egyed B, Kutszegi N, S\u00e1gi JC, G\u00e9zsi A, Rzepiel A, Visnovitz T, L\u0151rincz P, M\u00fcller J, Zombori M, Szalai C, Erd\u00e9lyi DJ, Kov\u00e1cs GT, Semsei \u00c1F (2020) MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia. J Transl Med 18(1):250. https:\/\/doi.org\/10.1186\/s12967-020-02415-8","journal-title":"J Transl Med"},{"issue":"16","key":"11244_CR68","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.3390\/cancers14163976","volume":"14","author":"I Kyriakidis","year":"2022","unstructured":"Kyriakidis I, Kyriakidis K, Tsezou A (2022) MicroRNAs and the diagnosis of childhood acute Lymphoblastic Leukemia: systematic review, meta-analysis and re-analysis with novel small RNA-Seq tools. Cancers (Basel) 14(16):3976. https:\/\/doi.org\/10.3390\/cancers14163976","journal-title":"Cancers (Basel)"},{"issue":"11","key":"11244_CR69","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","volume":"122","author":"DS Hong","year":"2020","unstructured":"Hong DS, Kang YK, Borad M, Sachdev J, Ejadi S, Lim HY, Brenner AJ, Park K, Lee JL, Kim TY, Shin S, Becerra CR, Falchook G, Stoudemire J, Martin D, Kelnar K, Peltier H, Bonato V, Bader AG, Smith S, Kim S, O'Neill V, Beg MS (2020) Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer 122(11):1630\u20131637. https:\/\/doi.org\/10.1038\/s41416-020-0802-1","journal-title":"Br J Cancer"},{"issue":"8","key":"11244_CR70","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/nar\/gkw116","volume":"44","author":"N Ludwig","year":"2016","unstructured":"Ludwig N et al (2016) Distribution of miRNA expression across human tissues. Nucleic Acids Res 44(8):3865\u20133877","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"11244_CR71","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23539","volume":"9","author":"F Ye","year":"2017","unstructured":"Ye F (2017) MicroRNA expression and activity in T-cell acute lymphoblastic leukemia. Oncotarget 9(4):5445","journal-title":"Oncotarget"},{"issue":"8","key":"11244_CR72","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/nmeth.3014","volume":"11","author":"P Mestdagh","year":"2014","unstructured":"Mestdagh P et al (2014) Evaluation of quantitative miRNA expression platforms in the MicroRNA quality control (miRQC) study. Nat Methods 11(8):809\u2013815","journal-title":"Nat Methods"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11244-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11244-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11244-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T02:02:33Z","timestamp":1763517753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11244-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11244"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11244-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}